Compumedics Ltd
ASX:CMP
Compumedics Ltd
Total Equity
Compumedics Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Compumedics Ltd
ASX:CMP
|
Total Equity
AU$23.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Somnomed Ltd
ASX:SOM
|
Total Equity
AU$46.4m
|
CAGR 3-Years
19%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Total Equity
AU$36.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
|
Cochlear Ltd
ASX:COH
|
Total Equity
AU$1.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Total Equity
AU$51.7m
|
CAGR 3-Years
31%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Total Equity
AU$19.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Compumedics Ltd
Glance View
Compumedics Ltd. is engaged in the research, development, manufacture and distribution of medical equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-12-21. The firm is engaged in development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The firm sells all its product offerings, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The firm sell its products throughout America’s, Australia and Asia Pacific, and Europe and the Middle East regions. Its United States business also includes sleep diagnostic services business. The firm product includes ONsight A.V.S., Grael PSG, Grael LT EEG System, Siesta 802, Grael 4K PSG:EEG, Grael 4K-EEG, Neuvo 64-512 Channel LTM EEG and CURRY. The Company’s subsidiaries include Compumedics USA Ltd, DWL USA Inc., Compumedics USA Inc, Compumedics Telemed Pty Ltd, Compumedics Medical Innovation Pty Ltd, Compumedics Cardiology Pty Ltd.
See Also
What is Compumedics Ltd's Total Equity?
Total Equity
23.4m
AUD
Based on the financial report for Dec 31, 2025, Compumedics Ltd's Total Equity amounts to 23.4m AUD.
What is Compumedics Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
6%
Over the last year, the Total Equity growth was 9%. The average annual Total Equity growth rates for Compumedics Ltd have been 12% over the past three years , 1% over the past five years , and 6% over the past ten years .
